Zur Startseite

Wie es funktioniert

Wir haben die Kliniksuche neu gestaltet — jetzt ist sie schnell, unkompliziert und persönlich.
Beantworten Sie ein paar FragenFüllen Sie ein kurzes Formular aus, um uns über Ihre Erkrankung und Ihre medizinischen Bedürfnisse zu informieren.
Personalisierte Angebote erhalten3 Kliniken, basierend auf Ihren Antworten ausgewählt, erstellen individuelle Behandlungspläne und Kostenvoranschläge.
Die beste Option wählenVergleichen Sie die Angebote und wählen Sie die Klinik, die am besten zu Ihnen passt.
Sie können auch alle 2 Kliniken unten durchsuchen.
820К+ Patienten haben seit 2014 Hilfe erhalten
50 Länder
1,500 Kliniken
6K+ Bewertungen
3K+ qualifizierte Ärzte

Wie hoch sind die Kosten für diagnostische Verfahren und Behandlungsverfahren für Blasenkrebs in China?

Bladder cancer treatment cost in China typically depends on the disease stage and required surgical intervention. Key procedures like bladder removal with reconstruction ranges from $24,000 to $48,500, while a standard bladder removal costs $19,500 to $41,000. Expenses are influenced by hospital tier and treatment complexity, often providing 40-60% savings compared to the US. Top cities for oncology include Guangzhou and Xiamen.

Typical Bladder Cancer Treatment Costs in China

  • Bladder removal with reconstruction: $24,000 – $48,500
  • Bladder removal: $19,500 – $41,000
  • Hyperthermic intraperitoneal chemotherapy (HIPEC): $22,500 – $48,500
  • Immunotherapy with Keytruda (pembrolizumab): $6,200 – $11,500
  • Oncothermia: Preis auf Anfrage
  • Actinium-225 therapy: $13,800 – $24,000
  • Radiation therapy: $11,500 – $27,500
  • Chemotherapy: $22,500 – $54,000

Bookimed Expert Insight: Patients with advanced or late-stage cancer benefit most from multidisciplinary centers offering specialized technologies. Fuda Cancer Hospital is a JCI-accredited facility focusing on minimally invasive cryosurgery and NanoKnife therapies. For those seeking innovative protocols, Xiamen Humanity Hospital provides access to Phase I–IV drug trials. These specialized institutions offer high-value care for complex cases that standard hospitals may not handle.

ChinaTürkeiÖsterreich
Strahlentherapie bei Darmkrebsvon $11,500von $7,000von $12,000
Immuntherapie mit Keytruda (Pembolizumab)von $6,200von $3,300von $15,000
Hyperthermische intraperitoneale Chemotherapie (HIPEC)von $22,500von $22,500von $40,000
Chemotherapie bei Brustkrebsvon $14,800von $1,200von $15,000
Blasenentfernung mit Rekonstruktionvon $24,000von $15,000von $32,000
Daten von Bookimed geprüft (Stand: June 2026), basierend auf Patientenanfragen und offiziellen Angeboten von 108 Kliniken weltweit. Die Durchschnittskosten basieren auf echten Rechnungen (2025–2026) und werden monatlich aktualisiert. Die tatsächlichen Kosten können variieren.

Die besten Kliniken für die Behandlung von Blasenkrebs in China: 2 geprüfte Optionen und Preise

Das Bookimed-Klinikranking basiert auf datenwissenschaftlichen Algorithmen und bietet einen vertrauenswürdigen, transparenten und objektiven Vergleich. Dabei werden die Patientennachfrage, Bewertungsergebnisse (sowohl positiv als auch negativ), die Häufigkeit von Aktualisierungen der Behandlungsoptionen und Preise, die Reaktionsgeschwindigkeit und die Klinikzertifizierungen berücksichtigt.
Fuda Cancer Hospital
Xiamen Humanity Krankenhaus

Die besten Spezialisten für Blasenkrebs in China — Sprechen Sie jetzt mit erfahrenen Ärzten

Alle Ärzte anzeigen
verifiziert

Liu Shi Xin

40 Jahre der Erfahrung

Professor Shixin Liu, MD, PhD, ist Fachbereichsleiter des Onkologiezentrums. Zuvor war er Präsident des Krebskrankenhauses der Provinz Jilin und Direktor des Forschungsinstituts für Krebsprävention und -therapie. Er ist Professor der zweiten Ebene und Promotionsbetreuer. Er erhielt die Sonderzulage des Staatsrats, die 4. Auszeichnung 'National Famous Doctor (Outstanding Contribution)' sowie den Ehrentitel 'Vorbild ärztlicher Ethik'.

Er ist auf die umfassende Diagnostik und Behandlung bösartiger Tumoren spezialisiert, mit Schwerpunkt auf präziser Strahlentherapie thorakaler und abdomineller Tumoren. Er beherrscht IMRT, VMAT und SBRT bei Lungen-, Speiseröhren-, Brust- und Rektumkarzinomen.

Zu seinen Leitungsfunktionen zählen die stellvertretenden Vorsitzämter bei CMA Radiation Oncology, CACA Radiotherapy und CACA Particle Therapy. Er gehört dem Ständigen Ausschuss der CSCO an und ist stellvertretender Vorsitzender des CSCO-Expertenkomitees für Strahlenonkologie. Zudem ist er stellvertretender Vorsitzender der CPAM Radiation Oncology und Mitglied des Ständigen Ausschusses der CSMEA. Er ist Vorsitzender der Sektion Strahlenonkologie der Jilin Medical Association. Er gehört den Redaktionsbeiräten des Chinese Journal of Radiation Oncology und des Practical Journal of Cancer an.

Diesen Inhalt teilen

Videogeschichten von Bookimeds Patienten

Dayana
Ich habe meinen Urlaub in Antalya mit einer medizinischen Untersuchung verbunden.
Verfahren: Frauenuntersuchung
Igor
Es war großartig! Transfer, Unterkunft, Behandlung – alles inklusive.
Verfahren: Zahnimplantat
Marina
Bookimed hat alles für mich erledigt. Ich musste mir um nichts Sorgen machen.
Verfahren: Frauenuntersuchung
Aktualisiert: 11/10/2025
Verfasst von
Mariia Mytrofankina
Mariia Mytrofankina
Copywriter (English und Deutsch)
Mehrsprachige medizinische Autorin mit über 5 Jahren Erfahrung und einem Master in Philologie und Übersetzung. Leitet Projekte zur globalen Gesundheitszertifizierung und LGBTQ+-Patientenversorgung.
Fahad Mawlood
Medizinischer Redakteur und Data Scientist
Allgemeinarzt. Gewinner von 4 wissenschaftlichen Preisen. Er diente in Westasien. Ehemaliger Teamleiter eines medizinischen Teams zur Betreuung arabischsprachiger Patienten. Jetzt Fahad ist verantwortlich für die Datenverarbeitung und die Genauigkeit der medizinischen Inhalte.
Fahad Mawlood Linkedin
Diese Seite enthält möglicherweise Informationen zu verschiedenen Erkrankungen, Behandlungen und Gesundheitsdiensten, die in verschiedenen Ländern verfügbar sind. Bitte beachten Sie, dass der Inhalt nur zu Informationszwecken bereitgestellt wird und nicht als medizinischer Rat oder Anleitung ausgelegt werden sollte. Bitte konsultieren Sie Ihren Arzt oder eine qualifizierte medizinische Fachkraft, bevor Sie eine medizinische Behandlung beginnen oder ändern.

Blasenkrebs -Behandlung in China

Diese FAQs stammen von echten Patienten, die über Bookimed medizinische Hilfe suchen. Die Antworten werden von erfahrenen medizinischen Koordinatoren und vertrauenswürdigen Klinikvertretern gegeben.

Are Chinese hospitals internationally accredited for bladder-cancer care?

Chinese oncology centers maintain international standards through Joint Commission International (JCI) accreditation. Facilities like Fuda Cancer Hospital in Guangzhou are JCI-accredited. These centers treat bladder cancer using advanced technologies. These include NanoKnife, cryosurgery, and immunotherapy drugs like Keytruda or Padcev.

  • Hospital accreditation: JCI certification confirms adherence to global patient safety standards.
  • Advanced technologies: Specialized centers utilize cryosurgery and NanoKnife for minimally invasive tumors.
  • Treatment volume: Fuda Cancer Hospital has served over 30,000 international oncology patients.
  • Clinical research: Facilities like Xiamen Humanity Hospital are accredited for phase I–IV drug trials.

Bookimed Expert Insight: While China has over 1,000,000 annual patients at major tertiary hospitals, only around 20 facilities hold JCI accreditation. Patients should look for specific oncology specializations in these JCI centers. For example, Fuda Cancer Hospital focuses specifically on late-stage cases with high-tech ablation tools.

Patient Consensus: Patients note that private JCI-accredited hospitals offer better hygiene and English-speaking staff. Many suggest hiring a private translator if choosing a large public university hospital in Shanghai.

What are the survival and cure rates for bladder-cancer surgery in China?

Bladder cancer surgery in China achieves an overall 5-year survival rate of approximately 71.5%. Outcomes reach 86.4% for early-stage patients treated with transurethral resection. Specialized tertiary centers report even higher survival rates near 74% due to advanced minimally invasive techniques and integrated oncological care.

  • Early-stage survival: Stage I patients report a 5-year overall survival rate of 86.4%.
  • Advanced-stage outcomes: Survival for muscle-invasive cancer ranges from 58.4% to 68% after surgery.
  • Surgical timing: Starting surgery within 90 days increases 5-year survival from 35.7% to 64.1%.
  • Institutional advantage: Specialized oncology centers exceed national averages, reaching up to 74% survival.

Bookimed Expert Insight: Choosing JCI-accredited facilities like Fuda Cancer Hospital provides access to specialized technologies like NanoKnife and cryosurgery. These clinics often manage higher patient volumes, with Xiamen Humanity Hospital serving 1,000,000 patients annually. Large-scale surgical experience at these centers typically correlates with better proficiency in complex bladder reconstructions.

Patient Consensus: Patients note that seeking treatment at top-tier hospitals in major cities significantly improves cure rates compared to regional clinics. Many emphasize that while robotic surgery options at private wings are more expensive, they offer better peace of mind regarding long-term recurrence.

Is robotic or laparoscopic cystectomy routinely offered, and what are the main safety advantages?

Robotic and laparoscopic cystectomy are routinely available at major Chinese oncology centers. These minimally invasive methods significantly reduce intraoperative blood loss and lower transfusion rates. Patients often experience shorter hospital stays and faster physical recovery compared to traditional open surgery approaches.

  • Blood loss: Procedures typically reduce intraoperative bleeding by approximately 40% to 50%.
  • Recovery time: Hospital stays often decrease to 3–5 days from the usual 7–10 days.
  • Precision: Robotic systems provide 3D high-definition visualization for delicate nerve-sparing dissection.
  • Complication rates: Minimally invasive techniques lead to fewer wound infections and post-operative clots.

Bookimed Expert Insight: Patient volume is the most critical safety indicator in China. Fuda Cancer Hospital serves over 30,000 international patients and specializes in over 10 types of minimally invasive therapies. Xiamen Humanity Hospital manages 1,000,000 patients annually as a major tertiary center. High-volume centers often provide more consistent outcomes for complex robotic bladder reconstructions.

Patient Consensus: Patients note that while open surgery remains common, robotic options are preferred for significantly lower transfusion risks. Many emphasize asking surgeons about their specific annual case volume to ensure the highest safety levels.

How soon can I fly home after a bladder operation in China?

Travelers from China should wait 2 to 4 weeks after major bladder surgery before flying. Minor procedures like cystoscopy may allow travel after 3 to 5 days. International patients must receive medical clearance from their surgeon. This timeline prevents blood clots and ensures safe healing at high altitudes.

  • Minor procedures: Diagnostic cystoscopy usually allows long-haul flight within 3 to 5 days.
  • Intermediate recovery: Procedures like transurethral resection typically require a 14-day wait before flying.
  • Major surgery: Radical cystectomy or bladder reconstruction often demands 4 to 6 weeks.
  • Airlines policies: Most carriers require a medical certificate for surgeries within 21 days.

Bookimed Expert Insight: While major centers like Xiamen Humanity Hospital serve 1,000,000 patients annually, individual recovery times vary. Fuda Cancer Hospital provides specialized minimally invasive options like NanoKnife and cryosurgery. These advanced techniques may reduce hospital stays. However, long-haul travel from China still requires strict adherence to the 14-day minimum. This timeframe prioritizes stability over early departure.

Patient Consensus: Patients note that cabin pressure can trigger bladder spasms weeks later. Many emphasize wearing compression socks and walking every hour during long-haul flights from China.

What is the typical in-country stay for bladder-cancer treatment?

In-country stays for bladder cancer treatment in China typically range from 1 to 12 days. Transurethral resection (TURBT) often allows same-day discharge or a 1-night stay. Complex procedures like radical cystectomy with reconstruction require 5 to 12 days in JCI-accredited hospitals.

  • Minimally invasive stay: Laparoscopic or robotic surgeries typically require 2 to 4 days.
  • Radical cystectomy stay: Major bladder removal surgery involves 5 to 12 hospital days.
  • Outpatient therapies: Intravesical BCG and drug-based immunotherapy generally require no overnight stay.
  • Advanced procedures: Specialized treatments like NanoKnife or cryosurgery often involve 2-3 hospital days.

Bookimed Expert Insight: China's high-volume oncology centers show a pattern of rapid post-operative turnover. Fuda Cancer Hospital manages over 30,000 international patients using minimally invasive techniques. These specialized therapies often reduce the typical 10-day surgical recovery to just 3 days. Patients should choose centers with JCI accreditation to ensure these shorter stays meet international safety standards.

Patient Consensus: Patients note it is important to plan for 2 to 3 weeks total in-country. This time covers the hospital stay plus outpatient follow-ups and visa logistics for a safe return home.

Will I have visible scars after minimally invasive bladder surgery?

Minimally invasive bladder surgery in China typically leaves 2 to 6 small, discreet scars. These keyhole incisions measure between 5 and 12 millimeters. Most scars fade significantly within 6 to 12 months. They often become thin, pale lines that are barely visible to the naked eye.

  • Incision size: Typical ports measure 0.5 to 1.2 centimeters, roughly the size of a pea.
  • Strategic placement: Surgeons often place incisions within the navel or along the natural bikini line.
  • Healing timeline: Redness usually fades over 12 months into flat, translucent, or skin-colored marks.
  • Advanced techniques: JCI-accredited facilities like Fuda Cancer Hospital utilize specialized minimally invasive oncology therapies.

Bookimed Expert Insight: Data from high-volume centers like Xiamen Humanity Hospital, which serves 1,000,000 patients annually, shows that surgical volume correlates with aesthetic outcomes. Specialized oncology centers in Guangzhou often prioritize multi-modal therapies over large-scale open surgeries. This focus on lung and bladder preservation frequently results in smaller, strategically placed ports that mature faster than standard laparoscopic incisions.

Patient Consensus: Patients note that 2 years after robotic surgery, small port scars often look like tiny freckles that no one notices. Many emphasize that keeping incisions covered from the sun for the first year is vital for preventing permanent darkening.

Which Chinese cities offer the highest volume bladder-cancer programmes for international patients?

Guangzhou, Beijing, and Shanghai host Chinas highest volume bladder cancer programs for international patients. These hubs feature JCI-accredited centers using advanced cryosurgery and NanoKnife technologies. Facilities like Fuda Cancer Hospital in Guangzhou have treated over 30,000 international patients from 100 countries.

  • Guangzhou hub: Fuda Cancer Hospital specializes in advanced-stage cases using minimally invasive therapies.
  • Beijing expertise: Peking University Cancer Hospital leads in multidisciplinary surgical and chemotherapy coordination.
  • Shanghai innovation: Fudan University centers provide advanced radiation, including proton and heavy ion therapy.
  • Xiamen capacity: Xiamen Humanity Hospital manages 1,000,000 annual patients across 47 clinical departments.

Bookimed Expert Insight: While Beijing and Shanghai are recognized for academic research, Guangzhou emerges as the practical leader for international accessibility. Fuda Cancer Hospital stands out because nearly 50% of its patient base is international. This high volume suggests better-established support systems for non-residents compared to general tertiary hospitals.

Patient Consensus: Patients note that while Beijing hospitals handle high caseloads, coordination can be complex. Many suggest hiring an independent translator to ensure staging reports and scans are clearly understood.

Kostenlose Beratung erhalten

Wählen Sie die beste Art und Weise, Sie zu kontaktieren